The trademark application XCUBE was filed by Immatics Biotechnologies GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on November 19, 2020, and it was registered by office on February 26, 2021 without any oppositions.
It was designated 'Basic Application' for International Application 1612922 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on April 5, 2022. Appointment and Replacement of representative of the trademark registration was recorded on August 21, 2022. Change of name and professional address of the trademark registration was recorded on August 2, 2023. Change of name and professional address of the trademark registration was recorded on October 2, 2024.
Goods And Services
The mark was filed in class 5 with Medical and veterinary preparations and articles, namely medicines for cancer treatment and natural remedies for cancer treatment and diagnostic agents and materials for cancer diagnostics.
The mark was filed in class 9 with following description of goods:
Bioinformatics software
Graphical user interface software
Artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS)
Electronic databases for bioinformatic purposes
Next-generation sequencing (NGS) data processor
Bioinformatics data processor
Computer software.
The mark was filed in class 35 with Compilation of statistical data and models with respect to cancer treatment and cancer diagnosis.
The mark was filed in class 42 with following description of goods:
Computer programming in the medical, pharmaceutical and biotechnological field
Database design
Database maintenance
Programming of software for importing and managing data
Information technology services for the pharmaceutical and healthcare industries
Computer programming for data processing
Non-downloadable computer software
Conducting evaluations in the field of pharmaceuticals
Consulting services in the fields of biotechnology and pharmaceutical research
Pharmaceutical product development and evaluation services
Pharmaceutical research and development
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Research and development of pharmaceuticals for the treatment of cancer
Technical research in the field of pharmaceutical studies
Development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics
Conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer
Collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments
Research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis
Providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine
Providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients
Providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice
Research and development services in the field of immunology.
The mark was filed in class 44 with Medical and pharmaceutical services.